Most recent articles by:

Editorial Team

- Advertisement -

AstraZeneca and RQ Biotech enter into licensing agreement to develop antibodies against COVID-19

UK-based startup and British-Swedish pharma giant AstraZeneca have signed a licensing agreement amounting to over $150 million. The agreement between the two...

Kelun sells cancer drug development rights to Merck in a deal worth $1.4 billion

United States-based Merck & Co has made an addition to its cancer-fighting drugs after entering into a contract with Chinese Pharmaceutical Company...

German Pharmaceutical and Medical Cannabis Products Distributor to be acquired by Franchise Global Health

The projected outcome of this acquisition is a boost in operations and the initiation of collaborations in the country, which is a...

Avillion and AstraZeneca combination medicine presents positive results for people living with asthma 

The New England Journal of Medicine has published the results of Avillion and AstraZeneca’s PT027 after participation in the MANDALA Phase III...

Orion signs $16 million deal with Jemincare for development of novel non-opioid pain treatment

The deal involves a $16 million payment from Orion to Jemincare with milestones as well as royalty payments. The tiered royalty payments...

Several drug recalls hit the US market, including Pfizer’s Accupril

Leading pharmaceutical companies have been hit by recalls recently. These U.S. based drugs  include Jubilant’s Methylprednisolone , Aurobindo Pharma’s Cyanocobalamin Injection, Sun...

Oral medication for Covid, Paxlovid boosted in Britain, courtesy of the national trial

Pfizer's COVID-19 immunization and antiviral give little indication of dialing back in the pandemic's third year. The company's oral treatment Paxlovid boost...

The European Commission allows Beovu to be used in the Treatment of DME

Following success in Phase III RCT KESTREL and KITE, Novartis’ Beovu will be used for diabetic macular edema The...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC
- Advertisement -